Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-Positive antibacterial activity
摘要:
Optimisation of the left-hand-side aryl moiety of a file compound screening hit against Staphylococcus aureus methionyl tRNA synthetase led to the identification of a series of potent nanomolar inhibitors. The best compounds showed excellent antibacterial activity against staphylococcal and enterococcal pathogens. including strains resistant to clinical antibiotics. (C) 2003 Elsevier Science Ltd. All rights reserved.
Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-Positive antibacterial activity
摘要:
Optimisation of the left-hand-side aryl moiety of a file compound screening hit against Staphylococcus aureus methionyl tRNA synthetase led to the identification of a series of potent nanomolar inhibitors. The best compounds showed excellent antibacterial activity against staphylococcal and enterococcal pathogens. including strains resistant to clinical antibiotics. (C) 2003 Elsevier Science Ltd. All rights reserved.
2-NH-heteroarylimidazoles with antibacterial activity
申请人:Berge John
公开号:US20060014748A1
公开(公告)日:2006-01-19
Compounds of formula (I):
are inhibitors of bacterial methionyl tRNA synthetase and are of use in treating bacterial infections.
公式(I)的化合物是细菌甲硫氨酸tRNA合成酶的抑制剂,可用于治疗细菌感染。
2-NH-HETEROARYLIMIDAZOLES WITH ANTIBACTERIAL ACTIVITY
申请人:Berge John
公开号:US20070213362A1
公开(公告)日:2007-09-13
A method of inhibiting MetRS activity comprises administering to a patient in need thereof a MetRS inhibiting effective amount of a compound of the formula (I). A method of treating a resistant or multiply-resistant
E. faecalis
infection, a resistant or multiply-resistant
S. aureus
infection, and/or a resistant or multiply-resistant
S. epidermidis
infection comprises administering to a patient in need thereof an antibacterially effective amount of a compound of the formula (I).